Does the BFNH Form 3 for Nexus Capital show any recent share purchases or sales?

No. The Form 3 functions as an initial statement of holdings and lists a direct position of 26,700,000 BFNH common shares without reporting any specific purchase or sale transactions.

BioForce Nano shareholder Nexus reports 26.7M shares

Q: What does the BFNH Form 3 filed for Nexus Capital Investments, Inc. report?

It reports Nexus Capital Investments, Inc. as a beneficial owner of BIOFORCE NANOSCIENCES HOLDINGS, INC., listing a direct holding of 26,700,000 shares of common stock, par value $0.001 per share, as of April 22, 2026.

Q: How many BFNH shares does Nexus Capital Investments, Inc. hold?

Nexus Capital Investments, Inc. holds 26,700,000 shares of BIOFORCE NANOSCIENCES HOLDINGS, INC. common stock as of April 22, 2026, reported as a direct ownership position.

Q: What is Nexus Capital Investments, Inc.’s ownership status in BFNH?

Nexus Capital Investments, Inc. is identified as a ten percent owner of BIOFORCE NANOSCIENCES HOLDINGS, INC., with a reported direct holding of 26,700,000 common shares on its Form 3.

Form 3 shows Nexus Capital Investments, Inc. directly holding 26.7 million BFNH common shares as of April 22, 2026.

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) disclosed an initial statement of beneficial ownership showing that Nexus Capital Investments, Inc. is a significant shareholder. Nexus Capital holds 26,700,000 shares of BFNH common stock, par value $0.001 per share, as a direct owner as of April 22, 2026.

A related note explains that Nexus Capital Investments, Inc. is owned 50% by Gretchen Privett and 50% by Zachary O'Shea.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nexus Capital Investments, Inc.

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock; Par Value $0.001 ^F1	--	--	--

Holdings After Transaction: Common Stock; Par Value $0.001 — 26,700,000 shares (Direct)

Footnotes (1)

F1. Nexus Capital Investments, Inc. is 50% owned by Gretchen Privett and 50% owned by Zachary O'Shea.

Key Figures

Common shares held: 26,700,000 shares Par value per share: $0.001 per share Ownership stake in Nexus Capital Investments, Inc. – Gretchen Privett: 50% +2 more

5 metrics

Common shares held 26,700,000 shares Directly owned by Nexus Capital Investments, Inc. as of April 22, 2026

Par value per share $0.001 per share Par value of BFNH common stock reported with the holdings

Ownership stake in Nexus Capital Investments, Inc. – Gretchen Privett 50% Gretchen Privett’s ownership of Nexus Capital Investments, Inc.

Ownership stake in Nexus Capital Investments, Inc. – Zachary O'Shea 50% Zachary O'Shea’s ownership of Nexus Capital Investments, Inc.

Insider status Ten percent owner Reporting person classification for Nexus Capital Investments, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BFNH Form 3 filed for Nexus Capital Investments, Inc. report?

It reports Nexus Capital Investments, Inc. as a beneficial owner of BIOFORCE NANOSCIENCES HOLDINGS, INC., listing a direct holding of 26,700,000 shares of common stock, par value $0.001 per share, as of April 22, 2026.

How many BFNH shares does Nexus Capital Investments, Inc. hold?

Nexus Capital Investments, Inc. holds 26,700,000 shares of BIOFORCE NANOSCIENCES HOLDINGS, INC. common stock as of April 22, 2026, reported as a direct ownership position.

What is Nexus Capital Investments, Inc.’s ownership status in BFNH?

Nexus Capital Investments, Inc. is identified as a ten percent owner of BIOFORCE NANOSCIENCES HOLDINGS, INC., with a reported direct holding of 26,700,000 common shares on its Form 3.

Who owns Nexus Capital Investments, Inc. mentioned in the BFNH Form 3?

According to a footnote, Nexus Capital Investments, Inc. is owned 50% by Gretchen Privett and 50% by Zachary O'Shea. This describes the ownership of the reporting entity itself, not a split of the BFNH shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/04/2026 - 12:49 PM EDT Accepted by SEC EDGAR 09/04/2026 - 12:48 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nexus Capital Investments, Inc.

(Last)

(First)

(Middle)

125 OLD MONROE ROAD

(Street)

ATHENS

GEORGIA

30606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/22/2026

3. Issuer Name and Ticker or Trading Symbol
BIOFORCE NANOSCIENCES HOLDINGS, INC. [ BFNH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock; Par Value $0.001	26,700,000	D⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Nexus Capital Investments, Inc. is 50% owned by Gretchen Privett and 50% owned by Zachary O'Shea.

	/s/Nexus Capital Investments, Inc., By: /s/Gretchen Privett, Authorized Officer	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR